Source link : https://www.newshealth.biz/health-news/fda-approves-second-ustekinumab-biosimilar/
The US Food and Drug Administration (FDA) has approved the biosimilar ustekinumab-aekn (Selarsdi) for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis in adults and pediatric patients aged 6 years or older. This is the second ustekinumab biosimilar approved by the regulatory agency and is the second biosimilar approval in the United […]
Author : News Health
Publish date : 2024-04-17 21:17:49
Copyright for syndicated content belongs to the linked Source.